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Abstract
Purpose The aim of this study was to analyse preoperative
risk factors for mortality or intensive care unit admission to
describe severe peritonitis.
Methods This was a single academic centre retrospective
study of consecutive adult patients operated for diffuse
secondary peritonitis between 2012 and 2013. Patients with
appendicitis or cholecystitis were excluded. Independent risk
factors were identified using binary and ordinal logistic
regression.
Results A total of 223 patients were analysed. Overall 30-day
mortality was 14.5 %. Postoperatively, 32.3 % of patients
were admitted into the intensive care unit (ICU).
Independent risk factors for severe peritonitis were septic
shock (odds ratio (OR) 37.94, 95 % confidence interval (CI)
14.52–99.13), chronic kidney insufficiency (OR 5.98 (95 %
CI 1.56–22.86), severe sepsis (OR 4.80, 95 % CI 2.10–10.65)
and cardiovascular disease (OR 2.58, 95 % CI 1.22–5.47).
Patients lacking these factors had nomortality. ICU admission
was refused in 24 (10.8 %) patients with 70.8 %mortality. In a
subgroup of patients without treatment limitations (n=190),
independent risk factors for weighted outcome of ICU admis-
sion or mortality were septic shock (OR 11.89, 95 % CI 4.98–
28.40), severe sepsis (OR 5.56, 95 % CI 2.39–12.89), meta-
static malignant disease or lymphoma (OR 3.11, 95 % CI
1.34–7.20) and corticosteroid use (OR 2.98, 95 % CI 1.18–
7.51). When receiving full level of care, patients with preop-
erative organ dysfunctions in this subgroup had 8.2 % 30-day
mortality.
Conclusions Preoperative organ dysfunctions, chronic kidney
insufficiency and cardiovascular disease are the most impor-
tant risk factors for severe peritonitis. Without these risk fac-
tors, patients had no mortality.
Keywords Laparotomy . Intraabdominal infections . Sepsis .
Critical care . Multiple organ failure
Introduction
Perforation of gastrointestinal (GI) tract leading to diffuse sec-
ondary peritonitis is a serious condition with substantial mor-
tality (20–40%) andmorbidity [1–3]. Peritonitis is classified as
diffuse (or generalised) if infection spreads widely into abdom-
inal cavity as opposed to local peritonitis in which infection is
limited into a part of abdominal cavity [1]. Diffuse peritonitis
forms about 40–45 % of all operatively managed abdominal
infections [4]. The most severe cases, associated with
persisting organ dysfunctions, are treated postoperatively in
intensive care unit (ICU) [1, 5]. These severe cases constitute
about 30–40 % of diffuse peritonitis with mortality up to 70 %
[1, 2, 4]. Elective gastrointestinal surgical operations are also
associated with a significant risk (5–10 %) of developing post-
operative peritonitis due to anastomotic dehiscence [1], with
associated mortality even higher compared to secondary
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peritonitis [6]. Abdominal infections are the second most com-
mon source for ICU-treated sepsis, following pulmonary infec-
tions [3]. The classic principles in treating secondary peritonitis
include intravenous fluid resuscitation, support of organ func-
tion, broad-spectrum systemic antimicrobial medication, time-
ly surgical source control, restoration of GI function and peri-
toneal lavage with evacuation of infectious material [7, 8]. It is
of great importance to identify patients at high risk of severe
peritonitis as early as possible since delays in antibiotic treat-
ment, fluid resuscitation and surgical source control have been
shown to increase mortality, even though the correct timing of
surgical source control is still controversial [8–11].
There are a number of studies and reviews that have
analysed and listed prognostic factors in peritonitis [1, 2, 4,
6, 12–15]. None of these previous studies specifically concen-
trate on preoperative variables. However, decisions of triage
for the operating room need to be done already in the emer-
gency department based on the available information. Also,
surgical decision making in the first operation has to be done
based on this information combined with the degree of ana-
tomical derangement. In a review article by Pieracci and
Barie, factors associated with mortality in secondary peritoni-
tis were shock, increasing age, increasing Acute Physiology
and Chronic Health Evaluation (APACHE) II score, isolation
of enterococci, impaired consciousness, inadequate empiric
antibiotics, poor nutritional status, cardiovascular disease, in-
ability to obtain source control, immunosuppression, hypoal-
buminemia, thrombocytopenia, diffuse versus localised peri-
tonitis, over 24-h delay before source definitive intervention,
subsequent nosocomial infection and protein C concentration
less than 66 % of normal [1].
The aim of this study was to analyse patients with diffuse
secondary peritonitis and identify association of readily avail-
able preoperative risk factors to severe peritonitis, which was
described as 30-day mortality or ICU admission.
Comprehending these risk factors would help in identifying
patients in the biggest risk for severe peritonitis and in need of
timely actions and new treatment strategies.
Material and methods
This study was conducted as a retrospective cohort study from
a single academic centre that serves both as a secondary and a
tertiary referral hospital. Institutional human research review
committee approved the study design. This study was an ob-
servational retrospective cohort study, and neither informed
consent nor ethics committee’s approval was needed.
Electronic operating room log was browsed for all abdominal
emergency surgery cases, which were further analysed from
electronic patient records, and all consecutive operatively
treated adult patients with diffuse secondary peritonitis due
to perforation in GI tract between January 1, 2012 and
December 31, 2013 were included in the study cohort.
Patients with appendicitis or cholecystitis were excluded due
to their better prognosis and straightforward treatment proto-
cols [2, 13, 16]. Further, four patients were excluded from the
study group because theywere already receiving ICU care due
to another disease (two patients with severe pancreatitis, one
early postoperative period after lung transplantation and one
postoperative period after operation for ruptured abdominal
aortic aneurysm) during the time of GI perforation.
Additionally, one patient was excluded since first operation
for peritonitis was done in another hospital. A total of 223
patients were included in the final study cohort.
Missing values are stated in the tables, and they were either
considered to be within reference values or discarded from
analysis depending on clinical rationale.
Definitions
Comorbidities were classified according to Charlson
Comorbidity Index (CCI) [17]. Other calculated scores includ-
ed APACHE II, Mannheim Peritonitis Index (MPI) and the
American Society of Anesthesiologists (ASA) physical status
classification [18, 19]. Sepsis was classified according to pre-
viously reported diagnostic criteria for sepsis, severe sepsis
(sepsis with organ dysfunction) and septic shock [5].
Signs of preoperative organ dysfunction were defined ac-
cording to Sequential Organ Failure Assessment (SOFA)
score of one point or more in each organ system when suffi-
cient data was available [20]. Due to the retrospective nature
of the data and emergency setting, it was not possible to define
exact SOFA scores. Instead, an extended criterion for organ
dysfunction was used in order to detect early organ dysfunc-
tion. When respiratory PaO2/FiO2 was not measured, pulse
oximetry saturation less than 90% or respiratory rate constant-
ly over 25 per minute was used. Because daily urine output
was not measurable in any of the acute patients, over 50% rise
in baseline plasma creatinine or hourly urine output less than
0.5 ml/kg under fluid resuscitation was used instead. When
mean arterial pressure (MAP) was not available in patients
who did not have an arterial line, the following equation
[(2×diastolic bp) + systolic bp]/3 to estimate MAP was used.
Main outcome was a composite outcome of 90-day mor-
tality or ICU admission.
Statistical analyses
Patient characteristics and perioperative data are presented in
number and percentage of patients, mean and median, range
and interquartile range (IQR) where appropriate. Statistical
analyses were performed using Fischer’s exact test, chi-
squared test, t test, logistic regression analysis with forward
stepwise selection and ordinal regression analysis where ap-
propriate. For continuous variables, Shapiro-Wilk’s test was
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used to define normality of distribution. Odds ratio (OR)
values are presented with 95 % confidence interval (CI), and
two-tailed p value below 0.05 was considered significant. For
logistic and ordinal regression analyses, robust and easily
measurable variables were chosen, which could be used in
clinical work. From univariate analysis, variables with
p<0.20 were chosen, however avoiding multicollinearity be-
tween variables. Cardiovascular diseases, other than arterial
hypertension, were combined as a single risk factor. In binary
logistic regression analysis, all variables were categorical,
goodness of fit was tested using Hosmer-Lemeshow test and
model performance was tested using Nagelkerke R2. In ordi-
nal logistic regression analysis, Pearson’s chi-squared
goodness-of-fit test and Nagelkerke R2 were used. Cutoff
points for factors in analyses were chosen according to defi-
nitions in previous studies, clinical sense and with the help of
receiver operating characteristic (ROC) curves.
All patients’ data were analysed more than 90 days post-
operatively. Analyses were performed using SPSS© Statistics
version 22 for Mac (IBM©, Armonk, NY, USA).
Results
Two-hundred and twenty-three patients with diffuse peritonitis
were analysed. Patient characteristics (Table 1) and intraopera-
tive and postoperative data (Table 2) are presented in distinct
tables to describe the study cohort, diagnoses, severity of co-
morbidities, preoperative physiology, intraoperative variables
and postoperative outcome. Shortly, patients had a mean age
of 63.3 years; 53.4 % were male, 93.6 % lived at home and
48.0 % were ASA class 4 (Table 1). Further, median MPI was
28; 25.6 % had a postoperative peritonitis, 54.7 % had perfora-
tion of the colon and 74.4% had a purulent peritonitis (Table 2).
Overall 30-day mortality was 14.5 % (n=33) and 90-day
mortality was 22.0 % (n=49). Postoperatively, 72 (32.3 %)
patients were admitted to the ICU with a 30-day mortality rate
of 16.7 % (n=12). The 30-day mortality rate for all non-ICU-
treated patients was 13.9 % (n=21).
Preoperative factors associated with 30-day mortality or
ICU admission in univariate analysis are presented in
Supplementary Table 1. Several preexisting conditions,
medications, emergency department findings and organ dys-
functions were significantly associated with ICU admission or
mortality. If patients had signs of severe sepsis (n = 46,
20.6 %) or septic shock (n=58, 26.0 %) at admission, 30-
day mortality rates were 21.7 and 29.3 % and ICU admittance
rates were 34.8 and 67.2 %, respectively.
In a multivariate logistic regression analysis, the severity of
sepsis, chronic kidney insufficiency and preexisting
cardiovascular disease were independent predictors of 30-
day mortality or ICU admission (Table 3). Area under receiver
operating characteristic (AUROC) for this multivariate model
Table 1 Patient characteristics
Baseline
Total number of patients 223
Sex, male/female, n (%) 119/104 (53.4/46.6)
Age, years, mean (range) 63.3 (17–94)
BMI, kg/m2, mean (range) 25.3 (13–51)a




Immunosuppressives (excluding corticosteroids) 17 (7.6)
Corticosteroids 41 (18.4)
Chemotherapy 32 (14.3)
Anticoagulants (chronic use) 36 (15.7)
Antithrombotics 41 (18.4)
Comorbidities, n (%)
Myocardial infarction 16 (7.2)
Congestive heart failure 26 (11.7)
Arteriosclerosis 19 (8.5)
Cerebrovascular disease (except haemiplegia) 26 (11.7)
Dementia 25 (11.2)
COPD 14 (6.3)
Connective tissue disease 18 (8.1)
Ulcer disease 57 (25.6)
Diabetes 38 (17.0)
Renal insufficiency (moderate or severe) 18 (8.1)
Haemiplegia 3 (1.3)
Malignancy 72 (32.3)
Malignant lymphoma 9 (3.9)
Solid malignant tumour
Without metastasis 26 (11.7)
With metastasis 34 (15.2)
Liver disease (moderate or severe) 3 (1.3)
AIDS 1 (0.4)
Coronary artery disease without infarction 31 (13.9)
Previous thromboembolic disease 21 (9.4)
Arterial hypertension 109 (48.9)
Charlson Comorbidity Index (CCI)
Mean (median) 2.6 (2)





4 or more 107 (48.0)
BMI n= 19, prehospital living conditions n= 2
BMI body mass index, COPD chronic obstructive pulmonary disease,
AIDS acquired immune deficiency syndrome, IQR interquartile range,
ASA American Society of Anesthesiologist
aMissing values (discarded from analysis)
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was 0.87 (CI 0.82–0.92, p < 0.001), Hosmer-Lemeshow
goodness-of-fit chi-squared test was 11.93 and degrees of
freedomwas 4 with significance 0.180, showing that the mod-
el has adequate fit. Model performance was tested using
Nagelkerke R2 with a result of 0.49.
When analysing patients with none of the independent risk
factors (n=86, 38.6 %), there was no 30-day mortality and
ICU admittance rate was 7.0 % (n=6). If patients had no signs
of organ dysfunction preoperatively (n=121, 54.3 %), the
rates were 5.0 % (n=6) and 14.0 % (n=17), respectively.
Twenty-four (10.8 %) patients were deemed too sick to
benefit from ICU treatment immediately postoperatively and
were refused ICU admission. This group had 70.8 % (n=17)
30-day mortality and 87.5 % (n = 21) 90-day mortality.
Characteristics of this patient group are summarised in
Table 4. These patients had a median age of 74 years;
20.8 % were institutionalised, 41.7 % had a metastatic malig-
nant disease or lymphoma and 83.4 % had signs of organ
dysfunction preoperatively. In the ICU, a decision to withdraw
life-sustaining treatment was done in 21 (9.4 %) patients, who
did not respond to care.
Patients who did not need ICU level care and limitation of
treatments were not made (n=106, 47.5 %) had no 30-day
mortality.
Subgroup analysis
An analysis of patients without limitations of treatment during
the first 3 days of hospitalisation (n=190; Table 5) was con-
ducted. This was done in order to separately analyse patients
who received full level of care with emphasis on mortality over
ICU admittance as outcome. In this group, 30-day mortality
was 4.7% (n=9) and 32.6% (n=62) of patients were admitted
into the ICU with 8.1 % (n=5) 30-day mortality. An ordinal
logistic regression analysis was done and as a dependent was
used a three-step outcome (no ICU admission or mortality,
ICU admission and 30-day mortality). Corticosteroid use, met-
astatic malignant disease or lymphoma and the severity of
sepsis were identified as independent risk factors (Table 5).
AUROC for ICU admission was 0.80 (CI 0.73–0.87,
p < 0.001) and for mortality was 0.91 (CI 0.85–0.97,
p<0.001). Pearson’s goodness-of-fit chi-squared test was
189.86, and degrees of freedom was 162 with significance
0.066, showing that the model has adequate fit. Model perfor-
mance was tested using Nagelkerke R2 with a result of 0.380.
Discussion
This retrospective single-centre cohort study of preoperative
prognostic factors in adult patients with diffuse secondary
peritonitis recognised several independent factors associated
with composite outcome of 30-day mortality or ICU
Table 2 Intraoperative and postoperative data
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Postoperative period, n (%)
ICU admittance 72 (32.3)










30/90-day mortality in ICU-admitted patients 12/19 (16.7/26.4)
Reoperations
Planned/unplanned 12/44 (5.4/19.7)










GI gastrointestinal, IQR interquartile range, ICU intensive care unit,
SOFA Sequential Organ Failure Assessment, DNR do not resuscitate
aMissing values (discarded from analysis), n= 6
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admittance. A composite outcome of 30-day mortality or ICU
admittance was chosen in order to recognise patients with
severe peritonitis. If these outcomes had been analysed sepa-
rately, the results would have been confusing because a group
of patients were refused of ICU admission. As a consequence,
the results from logistic regression analysis for ICU admit-
tance would have represented more ICU admission and refus-
al criteria than actual disease severity. Independent risk factors
in multivariate analysis in descending odds ratio order were
septic shock, severe sepsis, chronic kidney insufficiency and
cardiovascular disease. Patients lacking all of these risk factors
had no mortality, and only 7.0 % of these patients were ad-
mitted into the ICU.
In our data, patients can be generalised into three groups.
First group, about one half of patients, had no need for ICU
level care, had no comorbidities severe enough for treatment
limitations and had no mortality. Second group, approximate-
ly one third of patients, had a severe peritonitis with persisting
organ dysfunctions, received full level ICU care and had
16.7% 30-daymortality. Third group, every tenth patient, also
had a severe peritonitis but these patients were deemed too
sick to benefit from intensive care and had a very high mor-
tality (30 days 70.8 % and 90 days 87.5 %). Indeed, more than
half of the patients with a fatal outcome belonged to this
group. Decision to refuse ICU admission was done case by
case based on multiple factors, including poor functional sta-
tus or end-stage severe condition combined with acute organ
dysfunction.
In patients without any limitation of treatments during the
first 3 days after hospitalisation, the independent risk factors
for weighted outcome of ICU admission or death were septic
shock, severe sepsis, metastatic malignant disease or lympho-
ma and corticosteroid use. Overall 30-day mortality in this
subgroup was 4.7 %, and mortality amongst patients admitted
to the ICU was 8.1 %.
These results show little discrepancy with previous studies
or reviews [1, 2, 4, 6, 12–15]. The main difference is that this
study focuses on preoperative setting, in which the important
first decisions of treatment strategy are made. Also, patients
with appendicitis or cholecystitis, and better prognosis, were
excluded from this study, and as a consequence, overall dis-
ease severity can be considered higher. Development of organ
dysfunction, especially septic shock, is a critical risk factor for
mortality and ICU admittance. High suspicion and early rec-
ognition of organ dysfunctions in the emergency room are
essential in order to recognise patients with impaired progno-
sis. These patients should be diagnosed and treated with high
priority in the emergency room following timely surgical in-
tervention and ICU admission especially if preoperative signs
of organ dysfunctions do not rapidly respond to initial treat-
ments. Interestingly, in our data, one third of patients with
Table 3 Binary logistic
regression analysis of
preoperative risk factors for
composite outcome of 30-day
mortality or ICU admittance
Risk factor Composite outcome OR (95 % CI) p value
Cardiovascular disease 4.80 (2.16–10.65) 0.014











Method: forward LR, all variables categorical; contrast: indicator and reference category first
OR odds ratio, CI confidence interval, ICU intensive care unit
Table 4 Descriptive statistics of patients with immediate postoperative
ICU admission refusal (n= 24)
Characteristic n (%) or median (IQR)
Sex, M/F 13/11 (54.2/45.8)
Agea 74 (64.75–87.75)
Institutionalised 5 (20.8)
Metastatic malignant disease or lymphoma 10 (41.7)
Cardiovascular disease 12 (50.0)
Charlson Comorbidity Index 5 (1–6)
Mannheim Peritonitis Indexa 32 (28–35)
Sepsis classification severe/shock 7/13 (29.2/54.2)
IQR interquartile range, M/F male/female
aMedian (IQR)
Table 5 Ordinal regression analysis for patients without limitation of
treatments within 3 days of hospitalisation (n = 190) for weighted
outcome of ICU admission or 30-day mortality
Risk factor OR (95 % CI) p value
Corticosteroid use 2.98 (1.18–7.51) 0.021
Metastatic malignant disease or lymphoma 3.11 (1.34–7.20) 0.008
Sepsis classification
No organ dysfunction Reference
Severe sepsis 5.56 (2.39–12.89) <0.001
Septic shock 11.89 (4.98–28.40) <0.001
Ordinal regression dependent (no ICU or mortality, ICU admission, 90-day
mortality)
OR odds ratio, CI confidence interval
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signs of septic shock preoperatively were not admitted to the
ICU. In most of these patients, symptoms resolve during re-
suscitation, operation and recovery room period and some
patients were refused of ICU admission. In suspected sepsis
outside of the ICU, a recent study by Seymour et al. [21]
suggests the use of an intriguing novel bedside clinical score
termed quickSOFA (qSOFA; including respiratory rate of 22
per minute or greater, altered mentation or systolic blood pres-
sure of 100 mmHg or less) for screening. Such systematic
evaluation might be helpful in early identification of sepsis.
Patients with cardiovascular diseases, chronic kidney insuf-
ficiency or corticosteroid drug use are at higher risk of devel-
oping a severe disease, and this risk should be recognised in
surgical decision making as well as in supportive care. Other
immunosuppressive medications or delay over 24 h from on-
set of symptoms until operation did not significantly correlate
with outcome in univariate analysis. Due to nature of retro-
spective analysis, it is possible that shorter delays to surgery
were associated with more severe disease, thus causing bias
for effect of delay in the present study. Studies on effect of
surgical delay to outcome should have a more homogenic
cohort and a prospective study setting.
If patients had severe sepsis or septic shock at admission,
30-day mortality was 26.5 %. In a recent large Complex Intra-
Abdominal infection Observational (CIAO) study from
Europe [22], the mortality for patients with severe sepsis or
septic shock at admission was 32 %, which is comparable to
this study.
Mortality in patients admitted to ICU was 16.7 %, which is
remarkably low, compared to earlier studies made from the
same institution. In a study by Hynninen et al., ICU-treated
patients with non-postoperative and non-traumatic peritonitis
had a mortality of 40 % (patients treated between 2001 and
2003) [2]. Another study from our institution by Mulari et al.
studied patients with secondary peritonitis requiring ICU care,
and hospital mortality was 36 % (patients treated between
1996 and 1998) [12]. Overall, however, there seems to be
decreasing mortality rates in all ICU-treated patients with sep-
sis during the last decade [23]. But, it must be kept in mind
that ICU admission criteria are an important issue and very
closely associated with ICU mortality rates. In other words,
the more patients are deemed to be too sick and refused ICU
admission, the better the ICU mortality rates are. In fact, if we
combine ICU-refused patients (n=24) and ICU-treated pa-
tients (n=72), the combined mortality rate (17/24+12/72) is
more comparable (30.2 %) to study by Hynninen et al. [2]. In
our experience, more patients are refused ICU admission now-
adays than a decade ago. In order to make reported ICU mor-
tality rates comparable, ICU admission criteria and refusal
rates should be reported as well.
In Finland, mostly ICU-specialised anaesthesiologists
work as intensivists and run ICUs, serving also as gatekeepers.
It is well known that ICU treatment is expensive and resources
are limited [24]. Therefore, we think that it is of high impor-
tance to involve intensivists into decision-making process al-
ready in the preoperative phase. On the other hand, patients
with severe comorbidities should be diagnosed and treated
without delays in order that organ dysfunctions do not have
time to develop.
Patients lacking severe diseases and no signs of organ dys-
functions had no mortality. So, it seems that there is a struggle
between patients’ physiological reservoir and the quantum of
the insult given by the infection and inflammatory response.
Diffuse peritonitis with severe organ dysfunctions unrespon-
sive to initial treatments is a serious condition, but modern
ICU-level treatment for organ support is highly effective and
serves as an equaliser. Severe conditions with a risk of death or
ICU treatment can be predicted with good accuracy already
preoperatively, and these patients need to be prioritised for
timely interventions.
One unanswered and very important question for future
studies is that why do some patients get a very profound sepsis
and some patients do not develop organ dysfunctions after
diffuse peritonitis or recover from them instantly after resusci-
tative treatment and source control, even with similar anatom-
ical derangement and preexisting disease burden. And, is there
anything else we could do to stop the septic path? The under-
lying mechanisms of genomic inflammatory responses have
been studied vastly, but clinical breakthroughs are yet to be
discovered [25, 26]. At the moment, the best approach is most
likely to closely adherence into current sepsis guidelines [8].
The estimation of the prognosis of an individual patient is
difficult, but the results from this study provide some tools to
help surgeons and intensivists in decision-making process and
operating room prioritising.
This study has some limitations. Most importantly, this is a
retrospective and a single-centre study. The limited number of
patients in the study might affect some infrequent risk factors
not to become statistically significant. The retrospective na-
ture of the study sets limitations regarding missing data points
and possible inaccuracy of the collected data. At the same
time, all consecutive patients were collected with no age lim-
itations; therefore, this cohort reflects real-life patients accu-
rately. However, only operated patients were included and we
do not know how many patients were refused of operative
treatment during study period.
Conclusion
In conclusion, the risk for severe peritonitis can be predicted
effectively based on preoperative readily available risk factors.
The most important risk factors are septic shock, signs of
sepsis-related organ dysfunctions and preexisting cardiovas-
cular disease or chronic kidney insufficiency. Patients lacking
all of these risk factors had no mortality. In a subgroup of
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patients with no limitations of treatments, also, the use of
corticosteroids and metastatic malignant disease were identi-
fied as independent risk factors in addition to organ dysfunc-
tions. Since patients with diffuse peritonitis and organ dys-
functions have significant mortality, it is of paramount impor-
tance to diagnose and treat these patients effectively without
delays. Patients with severe comorbidities or poor functional
capacity have an extremely high mortality when refused of
ICU admission.
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